These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16525564)

  • 1. Inflammatory markers for risk stratification in primary prevention of cardiovascular disease: time for a 'multimarker' approach?
    Ikonomidis I; Lekakis J; Kremastinos DT
    Thromb Haemost; 2006 Mar; 95(3):397-8. PubMed ID: 16525564
    [No Abstract]   [Full Text] [Related]  

  • 2. ACE inhibition with perindopril and biomarkers of atherosclerosis and thrombosis: results from the PERTINENT study.
    Ceconi C; Fox KM; Remme WJ; Simoons ML; Deckers JW; Bertrand M; Parrinello G; Kluft C; Blann A; Cokkinos D; Ferrari R
    Atherosclerosis; 2009 May; 204(1):273-5. PubMed ID: 18950770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond C-reactive protein; new evidence for another inflammatory biomarker predicting cardiovascular disease risk.
    Kajinami K; Kawai Y
    Atherosclerosis; 2011 Jan; 214(1):39-40. PubMed ID: 21036356
    [No Abstract]   [Full Text] [Related]  

  • 4. C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study.
    Tuomisto K; Jousilahti P; Sundvall J; Pajunen P; Salomaa V
    Thromb Haemost; 2006 Mar; 95(3):511-8. PubMed ID: 16525580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein, inflammation, and cardiovascular disease: clinical update.
    Ridker PM
    Tex Heart Inst J; 2005; 32(3):384-6. PubMed ID: 16392225
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiinflammatory effects of L-carnitine supplementation (1000 mg/d) in coronary artery disease patients.
    Lee BJ; Lin JS; Lin YC; Lin PT
    Nutrition; 2015 Mar; 31(3):475-9. PubMed ID: 25701337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inflammatory hypothesis: any progress in risk stratification and therapeutic targets?
    Blankenberg S; Yusuf S
    Circulation; 2006 Oct; 114(15):1557-60. PubMed ID: 17030701
    [No Abstract]   [Full Text] [Related]  

  • 8. [Inflammation and C-reactive protein in cardiovascular disease].
    Munk PS; Larsen AI
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of inflammation in the pathogenesis of atherosclerosis].
    Banach M; Markuszewski L; Zasłonka J; Grzegorczyk J; Okoński P; Jegier B
    Przegl Epidemiol; 2004; 58(4):663-70. PubMed ID: 15810508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases.
    Li JJ; Fang CH
    Med Hypotheses; 2004; 62(4):499-506. PubMed ID: 15050096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk assessment in the patient with established peripheral arterial disease.
    Haugen S; Casserly IP; Regensteiner JG; Hiatt WR
    Vasc Med; 2007 Nov; 12(4):343-50. PubMed ID: 18048472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory cytokines and malnutrition as related to risk for cardiovascular disease in hemodialysis patients.
    Perunicic-Pekovic G; Pljesa S; Rasic-Milutinovic Z; Stankovic S; Ilic M; Maletic R
    Can J Physiol Pharmacol; 2008 Apr; 86(4):205-9. PubMed ID: 18418430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular disease. Does inflammation cut to the heart of the matter?
    Taubes G
    Science; 2002 Apr; 296(5566):242-5. PubMed ID: 11951014
    [No Abstract]   [Full Text] [Related]  

  • 14. Predicting CAD events: C-reactive protein a marker for atherosclerotic risk.
    MacKenzie JR
    Nurse Pract; 2004 Jun; 29(6):14-5, 19-27; quiz 27-9. PubMed ID: 15257119
    [No Abstract]   [Full Text] [Related]  

  • 15. C-reactive protein, inflammation, and coronary risk.
    Morrow DA; Ridker PM
    Med Clin North Am; 2000 Jan; 84(1):149-61, ix. PubMed ID: 10685132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Continuous Metabolic Syndrome Score Is Associated with Specific Biomarkers of Inflammation and CVD Risk in Prepubertal Children.
    Olza J; Aguilera CM; Gil-Campos M; Leis R; Bueno G; Valle M; Cañete R; Tojo R; Moreno LA; Gil Á
    Ann Nutr Metab; 2015; 66(2-3):72-9. PubMed ID: 25612676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive cardiology: move over low density lipoprotein cholesterol, hello C-reactive protein?
    Genest J
    Can J Cardiol; 2004 Aug; 20 Suppl B():89B-92B. PubMed ID: 15309211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Sensitivity C-Reactive Protein and Statin Initiation.
    Trpkovic A; Stanimirovic J; Rizzo M; Resanovic I; Soskic S; Jevremovic D; Isenovic ER
    Angiology; 2015 Jul; 66(6):503-7. PubMed ID: 25053677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation in coronary artery disease.
    Christodoulidis G; Vittorio TJ; Fudim M; Lerakis S; Kosmas CE
    Cardiol Rev; 2014; 22(6):279-88. PubMed ID: 24441047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein is an essential aspect of cardiovascular risk factor stratification.
    Yeh ET
    Can J Cardiol; 2004 Aug; 20 Suppl B():93B-96B. PubMed ID: 15309212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.